208 related articles for article (PubMed ID: 31217369)
1. The Therapeutic Effects of Baicalin on Vitiligo Mice.
Zhu Y; Zhong L; Peng J; Yuan Q; Xu A
Biol Pharm Bull; 2019 Sep; 42(9):1450-1455. PubMed ID: 31217369
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effects of EGCG on vitiligo.
Zhu Y; Wang S; Lin F; Li Q; Xu A
Fitoterapia; 2014 Dec; 99():243-51. PubMed ID: 25128425
[TBL] [Abstract][Full Text] [Related]
3. A quantitative increase in regulatory T cells controls development of vitiligo.
Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
[TBL] [Abstract][Full Text] [Related]
5. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
You S; Cho YH; Byun JS; Shin EC
Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
[TBL] [Abstract][Full Text] [Related]
6. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8⁺ T-cell accumulation in the skin.
Harris JE; Harris TH; Weninger W; Wherry EJ; Hunter CA; Turka LA
J Invest Dermatol; 2012 Jul; 132(7):1869-76. PubMed ID: 22297636
[TBL] [Abstract][Full Text] [Related]
7. A mouse model of vitiligo induced by monobenzone.
Zhu Y; Wang S; Xu A
Exp Dermatol; 2013 Jul; 22(7):499-501. PubMed ID: 23800067
[TBL] [Abstract][Full Text] [Related]
8. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.
Rashighi M; Agarwal P; Richmond JM; Harris TH; Dresser K; Su MW; Zhou Y; Deng A; Hunter CA; Luster AD; Harris JE
Sci Transl Med; 2014 Feb; 6(223):223ra23. PubMed ID: 24523323
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evidences of Pyrostegia venusta in the treatment of vitiligo.
Moreira CG; Carrenho LZ; Pawloski PL; Soley BS; Cabrini DA; Otuki MF
J Ethnopharmacol; 2015 Jun; 168():315-25. PubMed ID: 25862965
[TBL] [Abstract][Full Text] [Related]
10. Cytokines: the yin and yang of vitiligo pathogenesis.
Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3.
Boniface K; Jacquemin C; Darrigade AS; Dessarthe B; Martins C; Boukhedouni N; Vernisse C; Grasseau A; Thiolat D; Rambert J; Lucchese F; Bertolotti A; Ezzedine K; Taieb A; Seneschal J
J Invest Dermatol; 2018 Feb; 138(2):355-364. PubMed ID: 28927891
[TBL] [Abstract][Full Text] [Related]
12. Anatomically distinct fibroblast subsets determine skin autoimmune patterns.
Xu Z; Chen D; Hu Y; Jiang K; Huang H; Du Y; Wu W; Wang J; Sui J; Wang W; Zhang L; Li S; Li C; Yang Y; Chang J; Chen T
Nature; 2022 Jan; 601(7891):118-124. PubMed ID: 34912121
[TBL] [Abstract][Full Text] [Related]
13. Baicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy.
Mir-Palomo S; Nácher A; Ofelia Vila Busó MA; Caddeo C; Manca ML; Manconi M; Díez-Sales O
Colloids Surf B Biointerfaces; 2019 Mar; 175():654-662. PubMed ID: 30590326
[TBL] [Abstract][Full Text] [Related]
14. Antroquinonol Exerts Immunosuppressive Effect on CD8
Guan C; Li Q; Song X; Xu W; Li L; Xu A
Oxid Med Cell Longev; 2017; 2017():9303054. PubMed ID: 29456788
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of
Peng L; Lu Y; Gu Y; Liang B; Li Y; Li H; Ke Y; Zhu H; Li Z
Pharm Biol; 2023 Dec; 61(1):281-287. PubMed ID: 36655287
[TBL] [Abstract][Full Text] [Related]
16. IGF-1 resist oxidative damage to HaCaT and depigmentation in mice treated with H
Guan CP; Li QT; Jiang H; Geng QW; Xu W; Li LY; Xu AE
Biochem Biophys Res Commun; 2018 Sep; 503(4):2485-2492. PubMed ID: 30208515
[TBL] [Abstract][Full Text] [Related]
17. A similar local immune and oxidative stress phenotype in vitiligo and halo nevus.
Yang Y; Li S; Zhu G; Zhang Q; Wang G; Gao T; Li C; Wang L; Jian Z
J Dermatol Sci; 2017 Jul; 87(1):50-59. PubMed ID: 28385330
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo.
Chang Y; Kang P; Cui T; Guo W; Zhang W; Du P; Yi X; Guo S; Gao T; Li C; Li S
J Transl Med; 2023 Jul; 21(1):434. PubMed ID: 37403086
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune response against tyrosinase induces depigmentation in C57BL/6 black mice.
Al Robaee AA; Alzolibani AA; Rasheed Z
Autoimmunity; 2020 Dec; 53(8):459-466. PubMed ID: 33084421
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.
Agarwal P; Rashighi M; Essien KI; Richmond JM; Randall L; Pazoki-Toroudi H; Hunter CA; Harris JE
J Invest Dermatol; 2015 Apr; 135(4):1080-1088. PubMed ID: 25521459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
